Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer.
about
Nicotine and pathological angiogenesisAntiangiogenic mechanisms and factors in breast cancer treatmentTumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.Advanced imaging techniques in brain tumors.Inhibition of lung tumor growth in nude mice by siRNA(CD31) targeting PECAM-1.Bevacizumab suppression of establishment of micrometastases in experimental ocular melanomaSuccessful use of bevacizumb and paclitaxel in a male breast cancer with liver metastases.The Wnt signaling pathway: implications for therapy in osteosarcoma.Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases.Clinical implications of angiogenesis in cancers.Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo.In vitro the behaviors of metastasis with suppression of VEGF in human bone metastatic LNCaP-derivative C4-2B prostate cancer cell line.Clinical trials of antiangiogenic therapy in non-small cell lung cancer: focus on bevacizumab and ZD6474.Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma.Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy.Molecular targeted therapies for pancreatic cancer.EMMPRIN expression is required for response to bevacizumab therapy in HNSCC xenograftsCombined anti-proliferative and anti-angiogenic strategies for cancer.Borderline resectable pancreatic cancer: on the edge of survival.Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials.Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers.Endothelial nicotinic acetylcholine receptors and angiogenesis.Antibody-based cancer therapy.Beyond antiangiogenesis: intratumorally injected bevacizumab plays a cisplatin-sensitizing role in squamous cell carcinomas in mice.
P2860
Q24606748-DEAB4E49-F897-4478-B4D1-24D4EC0C18AFQ26751226-0EAD9BE6-7B6E-46B3-82BC-6970692E09C4Q33325343-F9C6A957-729E-4C82-88E0-B1A922938605Q33517391-6DB4A60F-5CE0-429F-BDE5-A4E86111A0C0Q33778468-F510362A-6A80-4B05-90B7-7B16B46C2C43Q33867266-416C6627-1519-4BC1-84BC-694144284925Q34415276-0582FCC9-D922-4226-8EA7-F3637A0A57C9Q34632285-2B466FA9-1A05-45BB-B8B9-A29D2999A6D6Q34763649-252FD4E9-D422-4DF0-99C0-281A4C35BB75Q36012979-F9FE6E26-EF29-449A-A164-2B57A6EC6482Q36388501-2D0E5337-3BAD-4186-B9ED-38FFD8D3EF53Q36438808-E01E1E45-11E9-4D16-B4E2-16945720D4F9Q36448683-F5D28C41-DFD3-4FA7-A5B8-731070D47D1EQ36508627-6B9A1988-50A2-4931-8F12-ED8D72219636Q36609877-9BB35197-5775-4613-A24B-191F7ABEE997Q36661727-FB7E9042-9729-4257-A139-5E12521061A0Q36944441-D7B2E1DD-61C1-4C15-AB86-407FCF7B3729Q37105489-3BCC886D-4FD7-47F9-920E-7B8D40C5AF97Q37111832-449741E2-6A0F-4CF5-A8C4-F13F1409E902Q37277969-454DF10E-E381-475F-90AB-33D0D629467DQ37301320-DE9195A2-89DE-4E54-9B5B-639917B840E8Q37354443-625DD208-7139-436B-80ED-08276159A1A7Q37397988-F663E293-11F0-4FF9-9B5D-96E26077013FQ38089186-4D055F13-629B-4454-BE14-6BF30FF4C70CQ39539497-923EB6CD-7FEB-4586-94CC-C2392B05041D
P2860
Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Investigating the potential of ...... pancreatic and breast cancer.
@ast
Investigating the potential of ...... pancreatic and breast cancer.
@en
type
label
Investigating the potential of ...... pancreatic and breast cancer.
@ast
Investigating the potential of ...... pancreatic and breast cancer.
@en
prefLabel
Investigating the potential of ...... pancreatic and breast cancer.
@ast
Investigating the potential of ...... pancreatic and breast cancer.
@en
P2860
P356
P1433
P1476
Investigating the potential of ...... pancreatic and breast cancer.
@en
P2860
P356
10.1159/000088483
P478
69 Suppl 3
P577
2005-11-21T00:00:00Z